2
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
294
Lymphoma
204
Lymphoma, Large B-Cell, Diffuse
168
Sarcoma
142
Precursor Cell Lymphoblastic Leukemia-Lymphoma
110
Hodgkin Disease
85
Lymphoma, Non-Hodgkin
79
Burkitt Lymphoma
67
Lymphoma, Follicular
62
Leukemia
58
Ovarian Neoplasms
51
Triple Negative Breast Neoplasms
50
Neoplasms
50
Lymphoma, Mantle-Cell
48
Multiple Myeloma
47
Carcinoma, Hepatocellular
47
Neuroblastoma
44
Neoplasm Metastasis
42
Lymphoma, B-Cell
33
Lymphoma, Large-Cell, Anaplastic
31
Recurrence
27
Lymphoma, T-Cell, Peripheral
27
Osteosarcoma
26
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
25
Liposarcoma
25
Leiomyosarcoma
25
Urinary Bladder Neoplasms
23
Lymphoma, Large-Cell, Immunoblastic
23
Liver Neoplasms
22
Endometrial Neoplasms
21
Interventions
Radiotherapy
4
Surveys and Questionnaires
3
Specimen Handling
2
Iohexol
2
Gemcitabine
2
spartalizumab
1
sodium thiosulfate
1
serotonin adipinate
1
liposomal doxorubicin
1
X-Rays
1
Watchful Waiting
1
Vorinostat
1
Surgical Procedures, Operative
1
Sunitinib
1
Solutions
1
Serotonin
1
Saline Solution
1
Re-Irradiation
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Probiotics
1
Platinum
1
Particle Accelerators
1
Pafolacianine
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lidocaine
1
Ketamine
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pelvic Neoplasms
×
Doxorubicin
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled